130 related articles for article (PubMed ID: 38561324)
1. Zinc-Iron Bimetallic Peroxides Modulate the Tumor Stromal Microenvironment and Enhance Cell Immunogenicity for Enhanced Breast Cancer Immunotherapy Therapy.
Lu Y; Chen Y; Hou G; Lei H; Liu L; Huang X; Sun S; Liu L; Liu X; Na J; Zhao Y; Cheng L; Zhong L
ACS Nano; 2024 Apr; 18(15):10542-10556. PubMed ID: 38561324
[TBL] [Abstract][Full Text] [Related]
2. A Bimetallic Polymerization Network for Effective Increase in Labile Iron Pool and Robust Activation of cGAS/STING Induces Ferroptosis-Based Tumor Immunotherapy.
Wang Z; Zhou P; Li Y; Zhang D; Chu F; Yuan F; Pan B; Gao F
Small; 2024 May; 20(20):e2308397. PubMed ID: 38072786
[TBL] [Abstract][Full Text] [Related]
3. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.
Yu J; Zhang Y; Li L; Xiang Y; Yao X; Zhao Y; Cai K; Li M; Li Z; Luo Z
Acta Biomater; 2023 Oct; 169():434-450. PubMed ID: 37516418
[TBL] [Abstract][Full Text] [Related]
4. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells.
Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D
Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer.
Wu J; Zhu Y; Luo M; Li L
Front Immunol; 2021; 12():748221. PubMed ID: 34659246
[TBL] [Abstract][Full Text] [Related]
6. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
7. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
[TBL] [Abstract][Full Text] [Related]
8. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract][Full Text] [Related]
9. Sonodynamic-immunomodulatory nanostimulators activate pyroptosis and remodel tumor microenvironment for enhanced tumor immunotherapy.
Chen Z; Liu W; Yang Z; Luo Y; Qiao C; Xie A; Jia Q; Yang P; Wang Z; Zhang R
Theranostics; 2023; 13(5):1571-1583. PubMed ID: 37056565
[No Abstract] [Full Text] [Related]
10. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate.
Lu Y; Xu F; Wang Y; Shi C; Sha Y; He G; Yao Q; Shao K; Sun W; Du J; Fan J; Peng X
Biomaterials; 2021 Nov; 278():121167. PubMed ID: 34624752
[TBL] [Abstract][Full Text] [Related]
11. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy.
Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L
Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331
[TBL] [Abstract][Full Text] [Related]
12. Precision therapy through breaking the intracellular redox balance with an MOF-based hydrogel intelligent nanobot for enhancing ferroptosis and activating immunotherapy.
Zhang D; Meng Y; Song Y; Cui P; Hu Z; Zheng X
Nanoscale; 2022 Jun; 14(23):8441-8453. PubMed ID: 35647731
[TBL] [Abstract][Full Text] [Related]
13. Heterostructural Nanoadjuvant CuSe/CoSe
Yang C; Wang M; Chang M; Yuan M; Zhang W; Tan J; Ding B; Ma P; Lin J
J Am Chem Soc; 2023 Apr; 145(13):7205-7217. PubMed ID: 36958054
[TBL] [Abstract][Full Text] [Related]
14. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
15. Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer immunotherapy.
Liu Y; Qi P; Chen G; Lang Z; Wang J; Wang X
Biomater Adv; 2024 Feb; 157():213758. PubMed ID: 38199000
[TBL] [Abstract][Full Text] [Related]
16. A Triple Therapeutic Strategy with Antiexosomal Iron Efflux for Enhanced Ferroptosis Therapy and Immunotherapy.
Wang Y; Chen Q; Song H; Zhang Y; Chen H; Liu P; Sun T; Jiang C
Small; 2022 Oct; 18(41):e2201704. PubMed ID: 36071027
[TBL] [Abstract][Full Text] [Related]
17. Fe-MnO
Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
[TBL] [Abstract][Full Text] [Related]
18. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
Prasad M; Zorea J; Jagadeeshan S; Shnerb AB; Mathukkada S; Bouaoud J; Michon L; Novoplansky O; Badarni M; Cohen L; Yegodayev KM; Tzadok S; Rotblat B; Brezina L; Mock A; Karabajakian A; Fayette J; Cohen I; Cooks T; Allon I; Dimitstein O; Joshua B; Kong D; Voronov E; Scaltriti M; Carmi Y; Conde-Lopez C; Hess J; Kurth I; Morris LGT; Saintigny P; Elkabets M
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35292516
[TBL] [Abstract][Full Text] [Related]
19. Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancer.
Li K; Xu K; He Y; Yang Y; Tan M; Mao Y; Zou Y; Feng Q; Luo Z; Cai K
ACS Nano; 2023 Mar; 17(5):4667-4687. PubMed ID: 36861638
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.
Niu X; Chen L; Li Y; Hu Z; He F
Semin Cancer Biol; 2022 Nov; 86(Pt 3):273-285. PubMed ID: 35288298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]